MedTrace Logo

Endothelial Microparticles: A Novel Marker of Vascular Dysfunction

NCT02230202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2018-02-28

No results posted yet for this study

Summary

The primary hypothesis of this proposal is that chronic kidney disease (CKD) and treatment with calcineurin inhibitors (CNIs) are each associated with the release of endothelial microparticles into the plasma.

Conditions

Interventions

OTHER

Flow-mediated dilation

Flow-mediated dilation used to measure vascular function. The test is minimally invasive, with only a slight discomfort due to the inflation of the arm cuff.

OTHER

single blood draw

single blood draw of approximately 45 mL.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Joshua M Thurman, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02230202 on ClinicalTrials.gov